Korea S.E.
06:00:00 2023-03-08 pm EST
5-day change
1st Jan Change
1,383
KRW
-27.44%
-.--%
-.--%
NewGLAB CO.,LTD announced that it has received KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
On July 19, 2019, NewGLAB CO.,LTD (KOSDAQ:A214870) closed the transaction. The company announced that it has extended bonds will mature on July 19, 2022 and will be convertible from July 19, 2020 to June 19, 2022.
NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors
Mar. 03
CI
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors
Feb. 21
CI
NewGLAB Pharma CO.,LTD(KOSDAQ:A214870) dropped from S&P Global BMI Index
23-06-19
CI
NewGLAB Pharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
22-04-04
CI
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
21-11-29
CI
NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding
21-03-21
CI
NewGLAB CO.,LTD announced that it expects to receive KRW 9.23 billion in funding
21-03-11
CI
NewGLAB CO.,LTD announced that it has received KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
20-10-19
CI
NewGLAB CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
20-09-27
CI
NewGLAB CO.,LTD announced that it has received KRW 18 billion in funding
19-11-07
CI
NewGLAB CO.,LTD announced that it expects to receive KRW 18 billion in funding
19-10-15
CI
NewGLAB CO.,LTD(KOSDAQ:A214870) added to S&P Global BMI Index
19-09-23
CI
NewGLAB CO.,LTD announced that it has received KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
19-07-18
CI
An unknown buyer acquired 3.8% stake in NewGLAB CO.,LTD from Ahrenel International.
19-06-03
CI
NewGLAB CO.,LTD announced that it has received KRW 10.000001088 billion in funding
19-04-28
CI
NewGLAB CO.,LTD announced that it has received KRW 5 billion in funding
19-04-11
CI
HDPRO Co., Ltd. announced that it expects to receive KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
18-12-18
CI
Arenel International Co., Ltd. acquired 13.1% stake in HDPRO Co., Ltd. from NextEye Co., Ltd. for KRW 11 billion.
18-12-18
CI
HDPRO Co., Ltd. announced that it expects to receive KRW 10.000001088 billion in funding
18-07-12
CI
HDPRO Co., Ltd. announced that it has received KRW 32.4999952 billion in funding
18-01-23
CI
HDPRO Co., Ltd. announced that it expects to receive KRW 5 billion in funding
17-12-28
CI
C&KY Holdings Co., Ltd. completed the acquisition of 14.14% stake in HDPRO Co., Ltd. from KODI CO., LTD.
17-10-29
CI
HDPRO Co., Ltd. announced that it has received KRW 10 billion in funding
17-10-23
CI
TS Holdings Co., Ltd. and 2 other shareholders completed the acquisition of 5.34% stake in HDPRO Co., Ltd. from C&KY Holdings Co., Ltd.
17-10-22
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
NewGLab Pharma Co Ltd, formerly NewGLab Co Ltd, is a company mainly engaged in the manufacturing and sale of closed-circuit television (CCTV) cameras. The Company's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The Company distributes its products within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-.--% 46.94M -3.82% 368B +20.99% 1.99B -17.84% 1.06B +64.31% 834M -3.30% 811M +5.94% 749M +44.37% 668M -33.47% 333M -11.03% 279M
Other Phones & Handheld Devices
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
NEWGLAB PHARMA CO.,LTD 
